MILANO VINCENT 4
4 · Aclaris Therapeutics, Inc. · Filed Jun 10, 2024
Insider Transaction Report
Form 4
MILANO VINCENT
Director
Transactions
- Award
Restricted Stock Units
2024-06-06+4,793→ 4,793 total→ Common Stock (4,793 underlying) - Award
Stock Option (Right to Buy)
2024-06-06+15,750→ 15,750 totalExercise: $1.03Exp: 2034-06-05→ Common Stock (15,750 underlying)
Footnotes (4)
- [F1]The shares subject to this option will vest in twelve equal monthly installments commencing July 6, 2024, subject to Reporting Person's continuous service through each such date.
- [F2]This grant was made pursuant to the issuer's ninth amended and restated non-employee director compensation policy.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F4]The shares underlying these restricted stock units will vest on June 6, 2025, subject to the Reporting Person's continuous service through such date.